Liaoning Chengda Biotechnology Co Ltd
SSE:688739

Watchlist Manager
Liaoning Chengda Biotechnology Co Ltd Logo
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Watchlist
Price: 26.71 CNY -4.02% Market Closed
Market Cap: 4.9B CNY
Have any thoughts about
Liaoning Chengda Biotechnology Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Liaoning Chengda Biotechnology Co Ltd

Wall Street analysts forecast Liaoning Chengda Biotechnology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Liaoning Chengda Biotechnology Co Ltd is 40.8 CNY with a low forecast of 40.4 CNY and a high forecast of 42 CNY.

Lowest
Price Target
40.4 CNY
51% Upside
Average
Price Target
40.8 CNY
53% Upside
Highest
Price Target
42 CNY
57% Upside
Liaoning Chengda Biotechnology Co Ltd Competitors:
Price Targets
2696
Shanghai Henlius Biotech Inc
13% Upside
2256
Abbisko Cayman Ltd
171% Upside
BAVA
Bavarian Nordic A/S
60% Upside
IMTX
Immatics NV
139% Upside
OXB
Oxford BioMedica PLC
25% Upside
VRDN
Viridian Therapeutics Inc
108% Upside
086890
Isu Abxis Co Ltd
97% Upside
PHM
Pharma Mar SA
7% Upside

Revenue
Forecast

Revenue Estimate
Liaoning Chengda Biotechnology Co Ltd

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 6%.

7%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Liaoning Chengda Biotechnology Co Ltd

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is 6%.

1%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Liaoning Chengda Biotechnology Co Ltd

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's net income is 1%. The projected CAGR for the next 3 years is -21%.

1%
Past Growth
-21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Liaoning Chengda Biotechnology Co Ltd's stock price target?
Price Target
40.8 CNY

According to Wall Street analysts, the average 1-year price target for Liaoning Chengda Biotechnology Co Ltd is 40.8 CNY with a low forecast of 40.4 CNY and a high forecast of 42 CNY.

What is Liaoning Chengda Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 6%.

What is Liaoning Chengda Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
6%

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is 6%.

What is Liaoning Chengda Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
-21%

For the last 10 years the compound annual growth rate for Liaoning Chengda Biotechnology Co Ltd's net income is 1%. The projected CAGR for the next 3 years is -21%.

Back to Top